What Should a Peptide Batch Record Contain?

A batch record should allow a technically competent reviewer to reconstruct what was planned, what actually happened and who verified critical actions. It links approved instructions to contemporaneous execution evidence.

For research peptides, the record chain usually spans raw materials, solid-phase synthesis, cleavage, purification, concentration, lyophilization, testing and packaging. Summary records can support buyer review, while full records may contain protected process details.

The header should define product code, sequence, modification state, target scale, batch number and governing procedure version. Materials should be traceable by internal or supplier lot, quantity and status at the time of use.

Equipment records should identify the synthesizer, purification system, lyophilizer and calibrated measuring devices used for critical steps. Cleaning or line-clearance references help show how mix-up and carryover risks were controlled.

Execution entries should capture cycle completion, deviations from set points, cleavage conditions, purification fractions, pooling rationale and isolation parameters at a level proportionate to risk. Automated data should remain linked to the batch.

Yield should be reconciled across meaningful stages using clearly defined wet, dry or peptide-content bases. Unexpected losses or gains require explanation because they may indicate transfer loss, incomplete drying, calculation error or record gaps.

Deviations, atypical observations, reprocessing and retesting should be visible rather than silently overwritten. Each event needs an assessment of batch impact, documented disposition and approval under the applicable quality process.

Final review confirms that required steps, reconciliations and tests are complete before status changes to released. The release decision should be attributable and linked to the approved specification and final COA.